Citation: | XUJian-ya, LISi-ying, XIETong, SHENCun-si, JIJian-jian, ZHOUHui-fang, SHANJin-jun. Evaluation of the Safety of Contraindicational Chinese Medicine in Pregnancy Based on the Strategy of Amniotic Fluid Metabolomics[J]. Journal of Nanjing University of traditional Chinese Medicine, 2019, 35(2): 223-228. |
[1] |
WANG CC, LI L, TANG LY, et al. Safety evaluation of commonly used Chinese herbal medicines during pregnancy in mice[J]. Hum Reprod, 2012, 27(8): 2448-2456.
|
[2] |
ANGELL M , KASSIRER JP.Alternative medicine-the risks of untested and unregulated remedies[J]. N Engl J Med, 1998, 339(12): 839-41.
|
[3] |
BUJAK R, STRUCK-LEWICKA W, MARKUSZEWSKI MJ, et al. Metabolomics for laboratory diagnostics[J]. J Pharm Biomed Anal, 2015, 113: 108-120.
|
[4] |
DU LN, XIE T, XU JY, et al. A metabolomics approach to studying the effects of Jinxin oral liquid on RSV-infected mice using UPLC/LTQ-Orbitrap mass spectrometry[J]. J Ethnopharmacol, 2015, 174: 25-36.
|
[5] |
WISHART DS.Emerging applications of metabolomics in drug discovery and precision medicine[J]. Nat Rev Drug Discov, 2016, 15(7): 473-484.
|
[6] |
SHI J, CAO B, WANG XW, et al. Metabolomics and its application to the evaluation of the efficacy and toxicity of traditional Chinese herb medicines[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2016, 1026: 204-216.
|
[7] |
PALMAS F, FATTUONI C, NOTO A, et al. The choice of amniotic fluid in metabolomics for the monitoring of fetus health[J]. Expert Rev Mol Diagn, 2016, 16(4): 473-486.
|
[8] |
FENG JH, YAN YE, LIANG G, et al. Maternal and fetal metabonomic alterations in prenatal nicotine exposure-induced rat intrauterine growth retardation[J]. Mol Cell Endocrinol, 2014, 394(1/2): 59-69.
|
[9] |
XIE HH, XU JY, XIE T, et al. Effects of Pinellia ternata (Thunb.) Berit. on the metabolomic profiles of placenta and amniotic fluid in pregnant rats[J]. J Ethnopharmacol, 2016, 183: 38-45.
|
[10] |
游云, 黄芳华, 韩玲.《中华人民共和国药典》收录孕妇禁用和慎用中药材生殖毒性研究进展[J]. 中国药理学与毒理学杂志, 2018, 32(5): 364-370.
|
[11] |
TANG LY, LI L, BORCHERT A, et al. Molecular studies of the congenital malformation induced by Largehead Atractylodes Rhizome, the most commonly used Chinese medicine for threatened miscarriage[J]. Mol Hum Reprod, 2012, 18(12): 585-592.
|
[12] |
SORENSEN D, SACKETT A, URBAN DJ, et al. A new mammalian model system for thalidomide teratogenesis: Monodelphis domestica[J]. Reprod Toxicol, 2017, 70: 126-132.
|
[13] |
VARGESSON N.Thalidomide-induced teratogenesis: History and mechanisms[J]. Birth Defects Res C Embryo Today, 2015, 105(2): 140-156.
|
[14] |
HAN JY, YAN Y, LIANG AH, et al. Thought and method of reproductive toxicity research in traditional Chinese medicine[J]. Acta Pharm Sin, 2014, 49(11): 1498-1503.
|
[15] |
LIANG B, LI L, TANG LY, et al. Safety of Chinese herbal medicines during pregnancy[J]. J Appl Toxicol, 2015, 35(5): 447-458.
|
[16] |
MADSEN R, LUNDSTEDT T, TRYGG J.Chemometrics in metabolomics: a review in human disease diagnosis[J]. Anal Chim Acta, 2010, 659(1/2): 23-33.
|
[17] |
NICHOLSON JK, LINDON JC.Systems biology: Metabonomics[J]. Nature, 2008, 455(7216): 1054-1056.
|
[18] |
GIL AM, DUARTE D. Biofluid metabolomics in preterm birth research[J]. Reprod Sci, 2018, 25(7): 967-977.
|
[19] |
DUNN WB, BROADHURST D, BEGLEY P, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry[J]. Nat Protoc, 2011, 6(7): 1060-1083.
|
[20] |
NICHOLSON JK, CONNELLY J, LINDON JC, et al. Metabonomics: a platform for studying drug toxicity and gene function[J]. Nat Rev Drug Discov, 2002, 1(2): 153-161.
|
[21] |
WANT EJ, WILSON ID, GIKA H, et al. Global metabolic profiling procedures for urine using UPLC-MS[J]. Nat Protoc, 2010, 5(6): 1005-1018.
|
[22] |
COURANT F, ANTIGNAC JP, MONTEAU F, et al. Metabolomics as a potential new approach for investigating human reproductive disorders[J]. J Proteome Res, 2013, 12(6): 2914-2920.
|
[23] |
AMORINI AM, GIORLANDINO C, LONGO S, et al. Metabolic profile of amniotic fluid as a biochemical tool to screen for inborn errors of metabolism and fetal anomalies[J]. Mol Cell Biochem, 2012, 359(1/2): 205-216.
|
[24] |
VIRGILIOU C, SAMPSONIDIS I, GIKA HG, et al. Development and validation of a HILIC-MS/MS multitargeted method for metabolomics applications[J]. Electrophoresis, 2015, 36(18): 2215-2225.
|
[25] |
FANOS V, ATZORI L, MAKARENKO K, et al. Metabolomics application in maternal-fetal medicine[J]. Biomed Res Int, 2013, 2013: 720514.
|
[26] |
PERSSON M, WINKVIST A, MOGREN I.Lifestyle and health status in a sample of Swedish women four years after pregnancy: a comparison of women with a history of normal pregnancy and women with a history of gestational diabetes mellitus[J]. BMC Pregnancy Childbirth, 2015, 15: 57.
|
[27] |
ORCZYK-PAWILOWICZ M, JAWIEN E, DEJA S, et al. Metabolomics of human amniotic fluid and maternal plasma during normal pregnancy[J]. PLoS ONE, 2016, 11(4): e0152740.
|
[28] |
O'NEILL K, ALEXANDER J, AZUMA R, et al. Gestational diabetes alters the metabolomic profile in 2nd trimester amniotic fluid in a sex-specific manner[J]. Int J Mol Sci, 2018, 19(9):2696.
|
[29] |
IADAROLA P, FUMAGALLI M, BARDONI AM, et al. Recent applications of CE- and HPLC-MS in the analysis of human fluids[J]. Electrophoresis, 2016, 37(1): 212-230.
|
[30] |
HUANG J, MO J, ZHAO G, et al. Application of the amniotic fluid metabolome to the study of fetal malformations, using down syndrome as a specific model[J]. Mol Med Rep, 2017, 16(5): 7405-7415.
|
[31] |
VIRGILIOU C, GIKA HG, WITTING M, et al. Amniotic fluid and maternal serum metabolic signatures in the second trimester associated with preterm delivery[J]. J Proteome Res, 2017, 16(2): 898-910.
|
[32] |
BARALDI E, GIORDANO G, STOCCHERO M, et al. Untargeted metabolomic analysis of amniotic fluid in the prediction of preterm delivery and bronchopulmonary dysplasia[J]. PLoS ONE, 2016, 11(10): e0164211.
|
[33] |
CHAFER-PERICAS C, STEFANOVIC V, SANCHEZ-ILLANA A, et al. Mass spectrometric detection of biomarkers for early assessment of intraamniotic fluid infection[J]. Data Brief, 2015, 5: 1026-1030.
|
[34] |
MADDIPATI KR, ROMERO R, CHAIWORAPONGSA T, et al. Clinical chorioamnionitis at term: the amniotic fluid fatty acyl lipidome[J]. J Lipid Res, 2016, 57(10): 1906-1916.
|
[35] |
MADDIPATI KR, ROMERO R, CHAIWORAPONGSA T, et al. Lipidomic analysis of patients with microbial invasion of the amniotic cavity reveals up-regulation of leukotriene B4[J]. FASEB J, 2016, 30(10): 3296-3307.
|
[36] |
BROWN AG, TULINA NM, BARILA GO, et al. Exposure to intrauterine inflammation alters metabolomic profiles in the amniotic fluid, fetal and neonatal brain in the mouse[J]. PLoS ONE, 2017, 12(10): e0186656.
|
[37] |
KIM SK, ROMERO R, SAVASAN ZA, et al. Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia[J]. Am J Reprod Immunol, 2013, 69(2): 105-123.
|
[38] |
GERVASI MT, ROMERO R, BRACALENTE G, et al. Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery[J]. J Perinat Med, 2012, 40(4): 329-343.
|
[39] |
REVELLO R, ALCAIDE MJ, DUDZIK D, et al. Differential amniotic fluid cytokine profile in women with chorioamnionitis with and without funisitis[J]. J Matern Fetal Neonatal Med, 2016, 29(13): 2161-2165.
|
[40] |
FATTUONI C, PALMAS F, NOTO A, et al. Primary HCMV infection in pregnancy from classic data towards metabolomics: An exploratory analysis[J]. Clin Chim Acta, 2016, 460: 23-32.
|
[41] |
FISCHER ST, LI LN, LI S, et al. Low-level maternal exposure to nicotine associates with significant metabolic perturbations in second-trimester amniotic fluid[J]. Environ Int, 2017, 107: 227-234.
|
[42] |
HUANG PC, TSAI CH, LIANG WY, et al. Early phthalates exposure in pregnant women is associated with alteration of thyroid hormones[J]. PLoS ONE, 2016, 11(7): e0159398.
|
[43] |
LOUGHHEAD AM, FISHER AD, NEWPORT DJ, et al. Antidepressants in amniotic fluid: Another route of fetal exposure[J]. Am J Psychiatry, 2006, 163(1): 145-147.
|
[44] |
DI VENERE M, VIGLIO S, CAGNONE M, et al. Advances in the analysis of "less-conventional" human body fluids: An overview of the CE- and HPLC-MS applications in the years 2015-2017[J]. Electrophoresis, 2018, 39(1): 160-178.
|
[45] |
ANTUNES NDE J, CAVALLI RC, MARQUES MP, et al. Influence of gestational diabetes on the stereoselective pharmacokinetics and placental distribution of metoprolol and its metabolites in parturients[J]. Br J Clin Pharmacol, 2015, 79(4): 605-616.
|
[46] |
BURRAI L, NIEDDU M, CARTA A, et al. Validated LC-MS-MS method for multiresidual analysis of 13 illicit phenethylamines in amniotic fluid[J]. J Anal Toxicol, 2016, 40(3): 194-200.
|
[47] |
SHAN JJ, XIE T, XU J, et al. Metabolomics of the amniotic fluid: Is it a feasible approach to evaluate the safety of Chinese medicine during pregnancy?[J]. J Appl Toxicol, 2019, 39(1): 163-171.
|